In a new study published in Brain, Behavior, and Immunity, researchers have found that cannabidiol, a compound derived from cannabis, can significantly reduce symptoms resembling post-traumatic stress disorder (PTSD) in mice. This effect hinges on cannabidiol’s ability to curb neuroinflammation through its interaction with specific receptors in the brain, known as CB2 receptors. These findings offer promising avenues for new PTSD treatments and underscore the potential of targeting the brain’s immune response to manage psychiatric disorders. PTSD is a severe mental health condition triggered b…